## Abstract Levodopaβinduced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFFβperiod dystonia, peakβdo
Levodopa-induced dyskinesia
β Scribed by Agid Yves
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 93 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract It has become increasingly apparent that Parkinson's disease involves many transmitter systems other than dopamine. This nondopaminergic involvement impacts on the generation of symptoms, on the neurodegenerative process, but, most tellingly, in the generation of side effects of current
## Levodopa-Induced Diphasic Dyskinesias Improved by Subcutaneous Apomorphine To the Editor: Levodopa-induced dyskinesias frequently complicate chronic levodopa therapy in patients with Parkinson's disease (1-3). They can be categorized as "peak-dose" dyskinesias (2), "off-period dystonias" (4), a